Arcutis EVP, Chief Medical Officer Patrick Burnett disposes of USD 392,075.19 in common shares

• Arcutis Biotherapeutics EVP, Chief Medical Officer Patrick Burnett exercised stock options on Aug. 11-12, acquiring 15,000 common shares at USD 3.64.
• Burnett sold 15,000 common shares on Aug. 11-12 at weighted-average prices of USD 26.52 and USD 26.08.
• Directly held common stock ended unchanged at 119,289 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-056898), on August 13, 2026, and is solely responsible for the information contained therein.